Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
NCT03171194
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
System; Lupus Erythematosus
Interventions
DRUG:
Low Dose Mesenchymal Stem Cells (MSCs)
Sponsor
Medical University of South Carolina